Tag: clinical trials

Training CRAs and Data Managers on Impact Assessment Criteria

November 20, 2025November 16, 2025 digi

Training CRAs and Data Managers on Impact Assessment Criteria Training CRAs and Data Managers on Impact Assessment Criteria In the realm of clinical research, ensuring compliance while maintaining participant safety and data integrity is paramount. Protocol deviations and non-compliance can have significant implications on the overall success of a clinical trial. This guide serves as…

Impact Assessment & Risk Categorization

Integrating Impact Assessments With CAPA and Quality Management Systems

November 20, 2025November 16, 2025 digi

Integrating Impact Assessments With CAPA and Quality Management Systems Integrating Impact Assessments With CAPA and Quality Management Systems In the realm of clinical research, especially in the context of astellas clinical trials, ensuring compliance and quality management is paramount for success. This comprehensive guide will outline the integration of impact assessments with Corrective and Preventive…

Impact Assessment & Risk Categorization

Training Clinical, Regulatory and Medical Teams on Plain-Language Summaries & Layperson Results

November 20, 2025November 16, 2025 digi

Training Clinical, Regulatory and Medical Teams on Plain-Language Summaries & Layperson Results Training Clinical, Regulatory and Medical Teams on Plain-Language Summaries & Layperson Results In the domain of clinical trials, the dissemination of results is a critical component of transparency and public trust. This article serves as a comprehensive guide for training clinical operations, regulatory…

Plain-Language Summaries & Layperson Results

Using Plain-Language Summaries & Layperson Results to Support Publications, HTA and Market Access

November 20, 2025November 16, 2025 digi

Using Plain-Language Summaries & Layperson Results to Support Publications, HTA and Market Access Using Plain-Language Summaries & Layperson Results to Support Publications, HTA and Market Access In the ever-evolving landscape of clinical trials, the importance of effective communication cannot be overstated. Particularly in the context of providing transparent and comprehensible information to patients, stakeholders, and…

Plain-Language Summaries & Layperson Results

Templates, Checklists and Governance Models for Robust Protocol Synopsis & Full Protocol

November 20, 2025November 16, 2025 digi

Templates, Checklists and Governance Models for Robust Protocol Synopsis & Full Protocol Templates, Checklists and Governance Models for Robust Protocol Synopsis & Full Protocol In the landscape of clinical trials, the integrity and clarity of both the protocol synopsis and the full protocol are fundamental to ensuring compliance with regulatory standards and achieving successful trial…

Protocol Synopsis & Full Protocol

Regulatory Expectations for Risk-Based Deviation Management

November 20, 2025November 16, 2025 digi

Regulatory Expectations for Risk-Based Deviation Management Regulatory Expectations for Risk-Based Deviation Management In the complex landscape of clinical trials, managing protocol deviations is paramount to ensure compliance with regulatory frameworks established by bodies such as the FDA, EMA, and MHRA. Understanding how to effectively navigate these deviations—particularly in the context of clinical trial logistics—is crucial…

Impact Assessment & Risk Categorization

Tools and Templates for Consistent Deviation Risk Scoring

November 20, 2025November 16, 2025 digi

Tools and Templates for Consistent Deviation Risk Scoring Tools and Templates for Consistent Deviation Risk Scoring Introduction to Deviation Risk Scoring in Clinical Trials Clinical trials play a critical role in the advancement of medical science and regulatory compliance, necessitating that every aspect of these trials is meticulously monitored and documented. One essential element of…

Impact Assessment & Risk Categorization

Integrating Plain-Language Summaries & Layperson Results With Data Privacy, GDPR and HIPAA Requirements

November 20, 2025 digi

Integrating Plain-Language Summaries & Layperson Results With Data Privacy, GDPR and HIPAA Requirements Integrating Plain-Language Summaries & Layperson Results With Data Privacy, GDPR and HIPAA Requirements In the realm of clinical research, the significance of transparency and effective communication cannot be overstated. The emergence of requirements for plain-language summaries and layperson results reinforces this necessity….

Plain-Language Summaries & Layperson Results

Vendor and Partner Oversight Considerations for Plain-Language Summaries & Layperson Results

November 20, 2025November 16, 2025 digi

Vendor and Partner Oversight Considerations for Plain-Language Summaries & Layperson Results Vendor and Partner Oversight Considerations for Plain-Language Summaries & Layperson Results In the evolving landscape of clinical trials, transparency remains a keystone, especially concerning layperson results and plain-language summaries. As the regulatory environment intensifies, especially within the jurisdictions of the FDA, EMA, and MHRA,…

Plain-Language Summaries & Layperson Results

Digital-First Protocol Synopsis & Full Protocol Strategies for Complex and Decentralized Trials

November 20, 2025November 16, 2025 digi

Digital-First Protocol Synopsis & Full Protocol Strategies for Complex and Decentralized Trials Digital-First Protocol Synopsis & Full Protocol Strategies for Complex and Decentralized Trials In the realm of clinical research, particularly within complex and decentralized trials, having robust protocol documentation is paramount. Protocols serve as a blueprint for the study, detailing the design, methodology, and…

Protocol Synopsis & Full Protocol